Samir Dave allotted 5.66% stake via preferential warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Samir Ramakant Dave, acting alone and not as a promoter, disclosed an allotment of 800,000 convertible warrants through a preferential issue on 22 October 2026. The warrants represent 5.66% of voting rights if all outstanding convertibles are converted. The company lists 75,45,056 equity shares and 1,41,45,056 shares on that fully converted basis.
The new holder could gain influence if the warrants are converted, while existing shareholders face possible dilution; no promoter sale or pledge is reported.